Masaya Tachibana

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Koichiro Ogata, Jeanne Mendell‐Harary, Masaya Tachibana et al. · The Journal of Clinical Pharmacology · 2010 · 448 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways

Na Zhao, Yingxue Ren, Yu Yamazaki et al. · Neuron · 2020 · 256 citations · Full text

Life Sciences, Genetics, Neuroscience +14

Vascular Cell Senescence Contributes to Blood–Brain Barrier Breakdown

Yu Yamazaki, Darren J. Baker, Masaya Tachibana et al. · Stroke · 2016 · 247 citations · Full text

Life Sciences, Cell Biology, Neuroscience +17

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Koji Izutsu, Shinichi Makita, Kisato Nosaka et al. · Blood · 2022 · 156 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1

Masaya Tachibana, Marie‐Louise Holm, Chia‐Chen Liu et al. · Journal of Clinical Investigation · 2019 · 154 citations · Full text

Life Sciences, Neurology, Neuroscience +17